ConductScience.org, home

Trial · NCT03296813

Results by group26

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
All-cause Mortality, as Measured by Follow-up Phone Call or NDITorsemide373Participants
All-cause Mortality, as Measured by Follow-up Phone Call or NDIFurosemide374Participants
All-cause Mortality or All-cause Hospitalization, as Measured by Follow-up Phone Call or NDI (for Death)Torsemide677Participants
All-cause Mortality or All-cause Hospitalization, as Measured by Follow-up Phone Call or NDI (for Death)Furosemide704Participants
Total Re-hospitalizations, as Measured by Follow-up Phone CallTorsemide940re-hospitalizations
Total Re-hospitalizations, as Measured by Follow-up Phone CallFurosemide987re-hospitalizations
All-cause Mortality or All-cause Hospitalization, as Measured by Follow-up Phone Call or NDI (for Death)Torsemide149Participants
All-cause Mortality or All-cause Hospitalization, as Measured by Follow-up Phone Call or NDI (for Death)Furosemide157Participants
Change in Health-related Quality of Life (QOL), as Measured by Follow-up Phone CallTorsemideBaseline to Month 169.5295% Confidence Interval 67.53 to 71.51score on a scale
Change in Health-related Quality of Life (QOL), as Measured by Follow-up Phone CallFurosemideBaseline to Month 168.2295% Confidence Interval 66.22 to 70.23score on a scale
Change in Health-related Quality of Life (QOL), as Measured by Follow-up Phone CallTorsemideBaseline to Month 670.6195% Confidence Interval 68.53 to 72.70score on a scale
Change in Health-related Quality of Life (QOL), as Measured by Follow-up Phone CallFurosemideBaseline to Month 671.0195% Confidence Interval 68.91 to 73.10score on a scale
Change in Health-related Quality of Life (QOL), as Measured by Follow-up Phone CallTorsemideBaseline to Month 1270.0095% Confidence Interval 67.85 to 72.15score on a scale
Change in Health-related Quality of Life (QOL), as Measured by Follow-up Phone CallFurosemideBaseline to Month 1269.9895% Confidence Interval 67.80 to 72.16score on a scale
Symptoms of Depression as Measured by the Patient Health Questionnaire-2 (PHQ-2)TorsemideMonth 1 / PHQ-2 score < 3790Participants
Symptoms of Depression as Measured by the Patient Health Questionnaire-2 (PHQ-2)FurosemideMonth 1 / PHQ-2 score < 3813Participants
Symptoms of Depression as Measured by the Patient Health Questionnaire-2 (PHQ-2)TorsemideMonth 1 / PHQ-2 score > = 3148Participants
Symptoms of Depression as Measured by the Patient Health Questionnaire-2 (PHQ-2)FurosemideMonth 1 / PHQ-2 score > = 3150Participants
Symptoms of Depression as Measured by the Patient Health Questionnaire-2 (PHQ-2)TorsemideMonth 6 / PHQ-2 score < 3658Participants
Symptoms of Depression as Measured by the Patient Health Questionnaire-2 (PHQ-2)FurosemideMonth 6 / PHQ-2 score < 3672Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03296813/results